Drug Type Synthetic peptide |
Synonyms bone disease peptide therapeutics (Alize Pharma III SAS) |
Target |
Mechanism IGFBP2 modulators(IGF binding protein-2 modulators), Osteoblasts stimulants, Osteoclasts inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Amolyt Pharma SASStartup |
Active Organization- |
Inactive Organization Amolyt Pharma SASStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis, Postmenopausal | Preclinical | US | Amolyt Pharma SASStartup | 28 Jun 2020 |